Point72 Asia Singapore Pte. Ltd. Makes New Investment in Beyond Air, Inc. (NASDAQ:XAIR)

Point72 Asia Singapore Pte. Ltd. bought a new stake in Beyond Air, Inc. (NASDAQ:XAIR) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 87,568 shares of the company’s stock, valued at approximately $47,000.

Separately, Gendell Jeffrey L grew its stake in shares of Beyond Air by 30.4% in the first quarter. Gendell Jeffrey L now owns 1,461,071 shares of the company’s stock valued at $2,542,000 after acquiring an additional 340,774 shares in the last quarter. 31.50% of the stock is currently owned by institutional investors.

Beyond Air Trading Up 6.6 %

NASDAQ XAIR opened at $0.39 on Tuesday. Beyond Air, Inc. has a twelve month low of $0.31 and a twelve month high of $2.61. The business’s fifty day moving average is $0.45 and its 200 day moving average is $0.92. The company has a quick ratio of 2.42, a current ratio of 2.63 and a debt-to-equity ratio of 0.84. The company has a market cap of $17.81 million, a price-to-earnings ratio of -0.21 and a beta of -0.11.

Beyond Air (NASDAQ:XAIR) last released its quarterly earnings data on Tuesday, August 6th. The company reported ($0.27) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.39) by $0.12. Beyond Air had a negative return on equity of 240.15% and a negative net margin of 3,272.46%. The company had revenue of $0.68 million during the quarter, compared to the consensus estimate of $0.72 million. During the same quarter in the prior year, the firm posted ($0.45) earnings per share. As a group, sell-side analysts expect that Beyond Air, Inc. will post -1.03 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CEO Steven A. Lisi bought 100,000 shares of the stock in a transaction that occurred on Wednesday, August 14th. The stock was acquired at an average cost of $0.39 per share, with a total value of $39,000.00. Following the transaction, the chief executive officer now directly owns 1,722,785 shares in the company, valued at $671,886.15. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 19.00% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of equities analysts have commented on XAIR shares. Roth Capital upgraded Beyond Air to a “strong-buy” rating in a research note on Friday, August 16th. Roth Mkm reaffirmed a “buy” rating and issued a $2.00 price target on shares of Beyond Air in a research note on Friday, August 16th. BTIG Research downgraded shares of Beyond Air from a “buy” rating to a “neutral” rating in a research note on Tuesday, June 25th. Finally, Piper Sandler dropped their target price on shares of Beyond Air from $3.50 to $1.00 and set an “overweight” rating for the company in a research report on Wednesday, August 7th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $3.67.

About Beyond Air

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.